| Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer (NCT05285579) | Assistance Publique - Hôpitaux de Paris | 2022-05-05 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. (NCT05363072) | Pfizer | 2022-05-02 |
| The Man Van Project (NCT06357416) | Royal Marsden NHS Foundation Trust | 2022-04-13 |
| Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry (NCT05210933) | University of Alberta | 2022-04-01 |
| Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells (NCT05108077) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-03-01 |
| Gag-layer in the Urothelium of the Human Upper Urinary Tract (NCT05400291) | Aarhus University Hospital | 2021-12-01 |
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT05119335) | NiKang Therapeutics, Inc. | 2021-10-26 |
| Renal Cancer Detection With Liquid Biopsy (NCT05060783) | Zealand University Hospital | 2021-07-01 |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) (NCT04498767) | European Organisation for Research and Treatment of Cancer - EORTC | 2021-06-10 |
| Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy (NCT04605146) | Hospices Civils de Lyon | 2021-05-05 |
| Impact of Perioperative Anesthetic Management on Renal Cancer Progression. (NCT06536244) | M.D. Anderson Cancer Center | 2020-07-31 |
| Microbiome Immunotherapy Toxicity and Response Evaluation (NCT04107168) | CCTU- Cancer Theme | 2020-07-08 |
| Assessment of Complications in Patients Who Underwent LPN According to the CCI (NCT05823545) | Samsun Liv Hospital | 2020-02-01 |
| Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors (NCT04157985) | Dan Zandberg | 2019-11-15 |
| Stereotactic Magnetic Resonance Guided Radiation Therapy (NCT04115254) | Dana-Farber Cancer Institute | 2019-10-22 |
| LPN in Patients With High-complex Renal Tumors (NCT04933604) | Samsun Liv Hospital | 2019-09-01 |
| Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer (NCT03390413) | Jørgen Bjerggaard Jensen | 2019-09-01 |
| Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study (NCT04392076) | University of Leeds | 2019-06-01 |
| Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker (NCT03927573) | AvenCell Europe GmbH | 2019-04-15 |
| MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour (NCT03934827) | Imperial College London | 2019-04-10 |
| Laparoscopic Partial Nephrectomy for cT1 Tumors (NCT04213157) | Samsun Liv Hospital | 2019-03-15 |
| Open vs Robotic Assisted Partial Nephrectomy (NCT03849820) | Intuitive Surgical | 2019-03-12 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Multiparametric MRI for Diagnosing Small Renal Tumors (NCT03470285) | University Hospital, Bordeaux | 2018-11-27 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors (NCT03755739) | Second Affiliated Hospital of Guangzhou Medical University | 2018-11-01 |
| A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors (NCT03693014) | Memorial Sloan Kettering Cancer Center | 2018-10-01 |
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) (NCT03634540) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-09-27 |
| Effects of Anesthesia on Immunity in Cancer (NCT03514550) | Meshalkin Research Institute of Pathology of Circulation | 2018-05-14 |
| Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants (NCT03568435) | Bristol-Myers Squibb | 2018-02-14 |
| Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence (NCT03679572) | University Hospital, Grenoble | 2018-02-05 |
| A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors (NCT03289962) | Genentech, Inc. | 2017-12-21 |
| Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) (NCT03203473) | Toni Choueiri, MD | 2017-10-26 |
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
| Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer (NCT03073395) | Five Eleven Pharma, Inc. | 2017-07-21 |
| Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR) (NCT03218319) | University Hospital, Angers | 2017-07-01 |
| Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma (NCT03024437) | Roberto Pili | 2017-06-29 |
| Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma (NCT03062410) | Centre Hospitalier Universitaire de Besancon | 2017-05-04 |
| Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02947165) | Novartis Pharmaceuticals | 2017-04-25 |
| Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Partial Nephrectomy? (NCT04388917) | Centre Hospitalier Universitaire de Nice | 2017-01-01 |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers (NCT02643303) | Ludwig Institute for Cancer Research | 2016-12-28 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (NCT02669914) | Washington University School of Medicine | 2016-09-12 |
| Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients (NCT02946671) | Osaka University | 2016-03-01 |
| Complications Associated With Partial Nephrectomy for Renal Cancer (NCT05168761) | Central Hospital, Nancy, France | 2016-01-01 |
| Decipher Genomics Resource for Intelligent Discovery (NCT02609269) | GenomeDx Biosciences Corp | 2015-10-01 |
| Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer (NCT02504892) | National Cancer Institute (NCI) | 2015-07-21 |
| Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis (NCT02457715) | Duke University | 2015-07-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence) (NCT02295982) | Zealand University Hospital | 2014-11-01 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive (NCT02153905) | National Cancer Institute (NCI) | 2014-07-03 |
| Prospective Analysis of Robot-Assisted Surgery (NCT02292914) | Instituto do Cancer do Estado de São Paulo | 2014-03-10 |
| Kidney Cancer DNA Registry (NCT02087852) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive (NCT02111850) | National Cancer Institute (NCI) | 2014-02-07 |
| Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment (NCT01888198) | Memorial Sloan Kettering Cancer Center | 2013-06-01 |
| Vascular Targeted Photodynamic Therapy T1a Renal Tumours (NCT01573156) | University of Oxford | 2013-05-01 |
| Off Clamp Randomization (NCT01732120) | Washington University School of Medicine | 2012-11-01 |
| A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) (NCT01608165) | Newcastle-upon-Tyne Hospitals NHS Trust | 2012-06-01 |
| Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes (NCT01606787) | Memorial Sloan Kettering Cancer Center | 2012-05-22 |
| Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma (NCT01582204) | Memorial Sloan Kettering Cancer Center | 2012-04-01 |
| BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) (NCT01453595) | Memorial Sloan Kettering Cancer Center | 2011-10-01 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (NCT01444456) | Amgen | 2011-10-01 |
| CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer (NCT01218867) | National Cancer Institute (NCI) | 2010-11-10 |
| Stereotactic Radiotherapy for Renal Cancers (NCT02811250) | Hospices Civils de Lyon | 2010-10-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies (NCT01109394) | National Cancer Institute (NCI) | 2010-04-21 |
| A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers (NCT01086696) | National Cancer Institute (NCI) | 2010-03-09 |
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) (NCT01138124) | GlaxoSmithKline | 2010-03-01 |
| Kidney Cancer Observational Protocol (NCT06147349) | IRCCS San Raffaele | 2010-01-27 |
| Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers (NCT01005797) | Medical University of South Carolina | 2009-11-01 |
| Percutaneous Renal Tumor Cryoablation Followed by Biopsy (NCT01012427) | Memorial Sloan Kettering Cancer Center | 2009-11-01 |
| Study In Patients With Kidney Cancer Treated With Sutent (NCT00873210) | Pfizer | 2009-05-01 |
| Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor (NCT00923390) | National Cancer Institute (NCI) | 2009-03-02 |
| Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma (NCT00827359) | Beth Israel Deaconess Medical Center | 2009-03-01 |
| Mechanisms of Anti-VEGF Induced Hypertension (NCT02156310) | Arduino Mangoni | 2009-01-01 |
| Follow-Up Study of Kidney Cancer Patients (NCT00656955) | National Cancer Institute (NCI) | 2008-04-17 |
| Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast (NCT00671411) | Memorial Sloan Kettering Cancer Center | 2008-03-01 |
| Phase II Study of Vandetanib in Individuals With Kidney Cancer (NCT00566995) | National Cancer Institute (NCI) | 2008-02-07 |
| Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (NCT00531284) | Amgen | 2007-09-01 |
| High-dose Bevacizumab in Advanced Renal Carcinoma Patients (NCT00455975) | SCRI Development Innovations, LLC | 2007-02-01 |
| Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma (NCT00418496) | Ohio State University Comprehensive Cancer Center | 2006-11-08 |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing (NCT00381173) | Eisai Inc. | 2006-11-01 |
| Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers (NCT00398814) | AEterna Zentaris | 2006-10-01 |
| Perifosine + Sunitinib Malate for Patients With Advanced Cancers (NCT00399152) | AEterna Zentaris | 2006-10-01 |
| A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies (NCT00441337) | Bristol-Myers Squibb | 2006-08-01 |
| CyberKnife for Unresectable Renal Tumors (NCT00807339) | Beth Israel Deaconess Medical Center | 2006-03-01 |
| Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 (NCT00199875) | Ludwig Institute for Cancer Research | 2005-07-06 |
| Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors (NCT00588276) | Memorial Sloan Kettering Cancer Center | 2005-06-01 |
| Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. (NCT00199888) | Ludwig Institute for Cancer Research | 2005-06-01 |
| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF (NCT00458536) | Beth Israel Deaconess Medical Center | 2004-10-01 |
| Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders (NCT00582621) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease (NCT00026884) | National Cancer Institute (NCI) | 1998-03-12 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma (NCT00293527) | Ohio State University Comprehensive Cancer Center | |